CVS Group (LON:CVSG) Insider Paul Higgs Acquires 1,235 Shares

CVS Group plc (LON:CVSGGet Free Report) insider Paul Higgs acquired 1,235 shares of the business’s stock in a transaction that occurred on Friday, December 5th. The stock was acquired at an average price of GBX 1,214 per share, for a total transaction of £14,992.90.

CVS Group Price Performance

Shares of CVSG stock opened at GBX 1,202 on Tuesday. The firm’s 50 day moving average price is GBX 1,263.48 and its two-hundred day moving average price is GBX 1,247.93. The company has a debt-to-equity ratio of 110.52, a quick ratio of 0.90 and a current ratio of 1.09. CVS Group plc has a 52-week low of GBX 800 and a 52-week high of GBX 1,648. The stock has a market cap of £853.88 million, a PE ratio of 16.33, a PEG ratio of 1.77 and a beta of 1.02.

CVS Group (LON:CVSGGet Free Report) last posted its quarterly earnings results on Tuesday, October 7th. The company reported GBX 80.10 earnings per share for the quarter. CVS Group had a return on equity of 7.86% and a net margin of 3.20%. As a group, analysts forecast that CVS Group plc will post 93.9393939 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Berenberg Bank reissued a “buy” rating and issued a GBX 2,000 target price on shares of CVS Group in a research note on Tuesday, November 18th. Jefferies Financial Group upped their price target on CVS Group from GBX 1,250 to GBX 1,420 and gave the company a “hold” rating in a research note on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft increased their price target on shares of CVS Group from GBX 1,500 to GBX 1,700 and gave the company a “buy” rating in a research report on Tuesday, October 21st. Peel Hunt restated a “buy” rating and set a GBX 1,600 price objective on shares of CVS Group in a report on Tuesday, November 18th. Finally, Royal Bank Of Canada upped their target price on shares of CVS Group from GBX 1,500 to GBX 1,900 and gave the company an “outperform” rating in a research note on Tuesday, October 21st. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of GBX 1,724.

View Our Latest Research Report on CVS Group

CVS Group Company Profile

(Get Free Report)

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.

Featured Stories

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.